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Abstract
Myocardial connexin 43 (Cx43) forms gap junctions and hemichannels, and is also present within subsarcolemmal mitochon-
dria. The protein is phosphorylated by several kinases including mitogen-activated protein kinase (MAPK), protein kinase 
C (PKC), and casein kinase 1 (CK1). A reduction in Cx43 content abrogates myocardial infarct size reduction by ischemic 
preconditioning (IPC). The present study characterizes the contribution of Cx43 phosphorylation towards mitochondrial 
function, hemichannel activity, and the cardioprotection by IPC in wild-type (WT) mice and in mice in which Cx43-phos-
phorylation sites targeted by above kinases are mutated to non-phosphorylatable residues  (Cx43MAPKmut,  Cx43PKCmut, and 
 Cx43CK1mut mice). The amount of Cx43 in the left ventricle and in mitochondria was reduced in all mutant strains compared 
to WT mice and Cx43 phosphorylation was altered at residues not directly targeted by the mutations. Whereas complex 1 
respiration was reduced in all strains, complex 2 respiration was decreased in  Cx43CK1mut mice only. In Cx43 epitope-mutated 
mice, formation of reactive oxygen species and opening of the mitochondrial permeability transition pore were not affected. 
The hemichannel open probability was reduced in  Cx43PKCmut and  Cx43CK1mut but not in  Cx43MAPKmut cardiomyocytes. 
Infarct size in isolated saline-perfused hearts after ischemia/reperfusion (45 min/120 min) was comparable between geno-
types and was significantly reduced by IPC (3 × 3 min ischemia/5 min reperfusion) in WT,  Cx43MAPKmut, and  Cx43PKCmut, 
but not in  Cx43CK1mut mice, an effect independent from the amount of Cx43 and the probability of hemichannel opening. 
Taken together, our study shows that alterations of Cx43 phosphorylation affect specific cellular functions and highlights 
the importance of Cx43 phosphorylation by CK1 for IPC’s cardioprotection.
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WT  Wild type
ZO-1  Zonula occludens 1
Introduction
Cell–cell communication in the ventricular myocardium is 
mediated via gap junctions, which are mainly formed by 
connexin 43 (Cx43). Six Cx43 proteins assemble into hex-
amers, the so-called connexons or hemichannels, and are 
transported to the sarcolemma, where two hemichannels 
from adjacent cells dock to each other and form gap junc-
tions, which allow the passage of molecules up to 1.5 kDa 
in size and mediate electrical and metabolic cell coupling. 
Cx43 is part of a family comprising 21 members in humans 
with molecular weights ranging from 26 to 60 kDa and 
which are expressed in different organs and cell types. The 
connexin secondary structure consists of four transmem-
brane domains and a cytosolic amino-and carboxytermi-
nus. Within the carboxyterminus of Cx43, at least 21 serine 
(S) residues are targeted and phosphorylated by different 
kinases, among them protein kinase B (PKB or AKT), 
protein kinase C (PKC), casein kinase 1 (CK1), calcium/
calmodulin kinase II (CamKII), mitogen-activated protein 
kinase (MAPK),  p34cdc2/cyclin B kinase (p34cdc2), and the 
pp60src kinase (src) (for review, see [69]).
S262 (similar to S279 and S282) is commonly suggested 
to be targeted by the extracellular-signal-related kinase 
(ERK) and the mutation of S262 to alanine increases gap 
junction permeability and inhibits desoxyribonucleic acid 
(DNA) synthesis. CK1 phosphorylates Cx43 at S325, S328, 
and S330 and mice in which S325/328/330 are mutated to 
alanines display disturbed gap junction formation and are 
susceptible to arrhythmias [54]. After phosphorylation of 
S373 by AKT, the interaction between Cx43 and zonula 
occludens 1 (ZO-1) is limited and the size of gap junctions 
is increased which may represent a first step in the disas-
sembly process of gap junctions. Cx43 phosphorylation at 
S365 is also involved in the protein–protein interaction with 
ZO-1. Dephosphorylation of Cx43 at S365 is essential for 
the phosphorylation of Cx43 at the PKC-target site S368; 
therefore, the Cx43 phosphorylation at S365 is suggested 
to function as a “gatekeeper” [71]. Cx43 S365 phospho-
rylation is increased under conditions where the activity of 
protein kinase A (PKA) is enhanced; however, Cx43 is a 
poor substrate for a direct phosphorylation by PKA. PKC 
directly phosphorylates Cx43 at S368 and this phosphoryla-
tion reduces the intercellular communication via gap junc-
tions. The role of Cx43 phosphorylation for gap junction 
dynamics, which is not only controlled by kinases but also 
by phosphatases [29], is reviewed in [69].
In addition to its localization at the sarcolemma, Cx43 
is also present at the inner membrane of mitochondria 
isolated from ventricular tissue [55, 73], especially in sub-
sarcolemmal mitochondria (SSM) and to a far lesser extent 
in interfibrillar mitochondria (IFM), which are located 
between the myofibrils [9, 75]. Compared to the detailed 
analysis of the phosphorylation of gap junctional Cx43, 
the phosphorylation of mitochondrial Cx43 is relatively 
unknown; however, phosphorylation at S262 and S368 has 
been detected [73, 76]. Within mitochondria, Cx43 influ-
ences mitochondrial respiration [7], formation of reactive 
oxygen species (ROS) [24, 68, 77], uptake of potassium 
ions [10], and opening of the mitochondrial permeability 
transition pore (MPTP) [20, 73].
Acute myocardial ischemia/reperfusion (I/R) injury 
elicits death of cardiomyocytes via necrosis, apoptosis, 
necroptosis, and pyroptosis (for review, see [26]). Both 
ischemic preconditioning (IPC) and ischemic postcon-
ditioning reduce myocardial infarct size after prolonged 
ischemia followed by reperfusion. In IPC, cycles of 
short, non-lethal episodes of ischemia/reperfusion (I/R) 
precedes the long-lasting ischemia, whereas in ischemic 
postconditioning, the short periods of I/R are applied at the 
onset of reperfusion following the long-lasting ischemic 
episode. Adenosine, bradykinin, opioids, and cytokines 
function as mediators or receptor-dependent triggers of 
cardioprotection. After a preconditioning stimulus, three 
major signaling pathways become activated, i.e., a) a path-
way involving eNOS, protein kinase G and PKC; b) the 
RISK pathway (reperfusion injury salvage kinase path-
way) including activation of AKT, ERK, and glycogen 
synthase kinase 3β; and c) the SAFE pathway (survival 
activating factor enhancement), in which cytokine recep-
tors and janus-kinase/signal transducer and activator of 
transcription proteins are induced [25, 26]. Besides target-
ing the sarcoplasmic reticulum, the nucleus, as well as the 
sarcolemma (including gap junctions and hemichannels), 
mitochondria represent a common endpoint of cardiopro-
tective maneuvers [6]. Whereas mitochondrial respiration 
declines after I/R, oxygen consumption is maintained after 
IPC. The role of ROS in the cardioprotection by IPC is 
complex: whereas IPC reduces the detrimental burst of 
ROS at the onset of reperfusion, small amounts of ROS 
also function as trigger molecules in the signaling cas-
cade of IPC [66]. In addition, opening of mitochondrial 
ATP-dependent potassium channels is important to reduce 
myocardial I/R injury and the opening of these channels 
leads to ROS formation which activate protein kinases 
involved in cardioprotective signaling (for review, see 
[25]). Conditions favoring opening of the MPTP, which 
elicits mitochondrial swelling, rupture, and finally cell 
death, are induced by ischemia [47], and both ischemic 
pre- and postconditioning induce cardioprotection via the 
inhibition of MPTP opening at reperfusion. Also, mito-
chondrial dynamics, i.e., fusion and fission, are involved in 
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I/R injury, whereby the inhibition of fission—and thereby 
a decreased fragmentation of mitochondrial networks—is 
effective in reducing I/R damage [49].
Cx43 is involved in myocardial I/R injury and also repre-
sents an important signaling molecule in the cardioprotection 
by IPC. The role of Cx43 in myocardial I/R damage com-
prises all aspects of Cx43 function: posttranslational modi-
fications, protein amount, alterations of gap junction, and 
hemichannel opening as well as mitochondrial function [60]. 
Whereas ischemia is often associated with a dephosphoryla-
tion and lateralization of Cx43 at the cardiomyocyte plasma 
membrane [60], Cx43 phosphorylation, and localization is 
maintained after IPC [56, 61]. The cardioprotection by IPC 
depends on the presence of Cx43, since the genetic reduction 
of Cx43 abrogates the infarct size reduction by IPC [59, 62, 
63]. Gap junctional coupling seems to be part of IPC’s car-
dioprotection, since blocking of Cx43-formed channels during 
the trigger phase abolishes the infarct size reduction of IPC 
[39] and IPC blocks chemical gap junctional coupling during 
ischemia (for review, see [46]). Plasmalemmal Cx43-formed 
hemichannels are predominantly closed under physiological 
conditions [1, 22], but they open after prolonged ischemia, 
which leads to cell swelling and finally cell death [65, 81]. 
Accordingly, the inhibition of Cx43-formed hemichannels 
by the peptide Gap19 reduces myocardial infarction after 
I/R [81] demonstrating the importance of the prevention of 
hemichannel opening for the reduction of myocardial damage 
after I/R. Since Cx43 affects mitochondrial function in several 
ways that influence cardioprotection [6, 12, 32], Cx43 within 
the the mitochondria is of special interest for myocardial I/R 
injury. Following I/R, phosphorylation of mitochondrial Cx43 
is decreased [76]. Mitochondrial Cx43 is also involved in IPC, 
since a specific reduction of mitochondrial Cx43 abrogates 
preconditioning [55] and overexpression of mitochondrial 
Cx43 is sufficient to induce cell protection [43].
It is noteworthy that although ischemic postconditioning 
alters Cx43 phosphorylation [5, 23, 50], infarct size is effec-
tively reduced in heterozygous Cx43-deficient mice [27]. 
Thus, despite its relevance for the cardioprotection by IPC, 
ischemic postconditioning is not dependend on Cx43.
Whereas Cx43 clearly contributes to I/R response, the 
role of Cx43 phosphorylation on the regulation of mitochon-
drial function, cardiomyocyte hemichannel activity, and car-
dioprotection by IPC is heretofore not well studied and, thus, 
is the goal of the present study.
Materials and methods
Animals
The generation of the mouse strains  Cx43MAPKmut, 
 Cx43PKCmut, and  Cx43CK1mut has been described previously 
[30, 34]. In the line  Cx43MAPKmut, serines 255, 262, 279, and 
282 (which are targeted by MAPK) were replaced by non-
phosphorylatable alanine residues; in the line  Cx43PKCmut, 
the PKC-targeted residue serine 368 was replaced by ala-
nine, and in the line  Cx43CK1mut, serines at positions 325, 
328, and 330 were replaced by alanine, tyrosine, and alanine, 
respectively. Mutated mice were backcrossed with C57Bl6/J 
mice for 10 generations (Fred Hutchinson Cancer Research 
Center). At the University of Giessen, mutated mice were 
backcrossed with C57Bl6/J mice after every 6–8 genera-
tions  (Cx43MAPKmut), after 10 generations  (Cx43PKCmut), 
and after 4–6 generations  (Cx43CK1mut). C57Bl6/J mice 
(Janvier, Le Genest-Saint-Isles, France) served as controls. 
In addition, inducible Cx43 knockout mice  (Cx43Cre−ER(T)/fl) 
which express 50% of Cx43 were studied [16]. Both male 
and female mice of 12–22 weeks of age (18–34 g) were ana-
lyzed. Mice were kept in dark/light cycles of 12 h each and 
had free access to standard chow and drinking water. The 
present study conforms to the Guide for the Care and Use of 
Laboratory Animals published by the US National Institutes 
of Health (NIH publication No. 85–23, revised 1996) and is 
in accordance with the ARRIVE (Animal research: Report-
ing in vivo experiments) guidelines. The study was approved 
by the animal welfare office of the Justus-Liebig-University 
Giessen, Germany (522_M) and by the committee on ethical 
usage of animals of Ghent University (ECD16-24.)
Isolation of subsarcolemmal mitochondria
Subsarcolemmal mitochondria (SSM) were isolated from 
left-ventricular (LV) tissue by differential centrifugation as 
already described [11] and were used to study mitochondrial 
function immediately after isolation. For Western Blot anal-
ysis, mitochondria were further purified by Percoll-gradient 
ultracentrifugation and were stored at − 80 °C. The purity of 
all mitochondrial preparations was verified by Western Blot 
analysis (Supplementary Fig. 3).
Western Blot analysis
Protein extraction from LV tissue samples and isolated mito-
chondria is described in detail in the online supplement. 
Antibodies were used against total Cx43, Cx43 phospho-
rylated at S262, S325/328/330, S365, S368, and S373. Anti-
bodies against glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) and manganese superoxide dismutase (MnSOD) 
were used for normalization of total and mitochondrial pro-
teins, respectively.
Mitochondrial respiration
Mitochondrial oxygen consumption was measured from 
100  µg/ml mitochondrial proteins with a Clark-type 
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electrode (Strathkelvin, Glasgow, UK) at 25 °C using glu-
tamate and malate as substrates for complex 1 and succi-
nate (in the presence of rotenone to inhibit complex 1) as 
substrate for complex 2. In addition, complex 4-mediated 
respiration was analyzed in the presence of N,N,N′,N′-
tetramethyl-p-phenylenediamine (TMPD) and ascorbate, 
and uncoupling of oxidative phosphorylation was induced 
by the addition of FCCP (cyanide 4-(trifluoromethoxy)phe-
nylhydrazone). Respiration was stimulated by the addition 
of 40 µmol/L ADP. Oxygen consumption is shown in nmol 
 O2*min−1*mg  protein−1 [4].
Formation of reactive oxygen species
ROS formation was detected from 50 µg mitochondrial pro-
teins using 50 µmol/L AmplexUltraRed. Background fluo-
rescence without mitochondria was subtracted and the slope 
of the fluorescence signal was calculated for 2 min [4].
Calcium‑induced MPTP opening
The calcium retention capacities of 100 µg/ml SSM with 
glutamate and malate were measured at 25 °C in the pres-
ence of 0.5 µmol/L Calcium Green 5 N. Five µmol/L  CaCl2 
were added every third minute until a sudden increase in 
Calcium Green 5 N fluorescence occurred reflecting MPTP 
opening [4]. As a positive control, measurements were per-
formed in the presence of 1 µmol/L Cyclosporine A (CsA), 
which inhibits MPTP opening.
Cardiomyocyte isolation and electrophysiological 
recordings
The isolation of LV cardiomyocytes from wild-type (WT), 
 Cx43MAPKmut,  Cx43PKCmut, and  Cx43CK1mut mice was per-
formed as previously described [42]. Mice were sacri-
ficed by cervical dislocation. Following thoracotomy, the 
heart was quickly excised and transferred to a Langendorff 
apparatus and perfused at a constant flow (~ 3 ml/min) and 
temperature (37 °C).  Ca2+-tolerant cells were used for the 
experiment within 6 h after isolation. Cardiomyocytes were 
studied using whole-cell voltage-clamp to record membrane 
currents. Patch-clamp experiments were conducted at room 
temperature (22 ± 1 °C).
Ischemia/reperfusion in vitro
Isolated mouse hearts were Langendorff-perfused as already 
described [4]. The I/R protocol comprised of a 5 min sta-
bilization phase, followed by 45 min ischemia and 120 min 
reperfusion. IPC was performed by three preceding cycles 
of 3 min ischemia and 5 min reperfusion. At the end of 
the protocol, myocardial infarction was delineated by 
triphenyltetrazolium chloride (TTC) staining and quantified 
by planimetry [4].
Statistics
Data are presented as mean ± SEM. Western Blot data on the 
amount of Cx43 in total and mitochondrial protein extracts 
were compared by non-parametric Rank Sum test, and 
Western Blot data on phosphorylated Cx43, ROS forma-
tion, opening of Cx43-formed hemichannels, and sodium/
calcium exchanger (NCX) parameters were analyzed by 
unpaired two-sided t test. The amount of phosphorylated 
and total Cx43 in isolated cardiomyocytes was compared by 
paired t test. The amount of mitochondrial protein isolated 
from LV tissue was compared by one-way ANOVA. Data on 
heart weight and heart weight/body weight, mitochondrial 
respiration, calcium-induced MPTP opening, myocardial 
infarction, end-diastolic pressure (EDP), and left-ventric-
ular developed pressure (LVDP) were compared by two-
way ANOVA followed by Holm–Sidak test. Analyses were 
done with SigmaStat 3.5 (Systat, Software GmbH, Erkrath, 
Germany) and OriginLab software (OriginLab Corporation, 
USA). A p value < 0.05 was considered to indicate a signifi-
cant difference.
A detailed description of the Methods is given in the 
online supplement.
Results
The amount of Cx43 was measured by Western Blot anal-
ysis in total LV protein extracts of WT,  Cx43MAPKmut, 
 Cx43PKCmut, and  Cx43CK1mut mice, respectively (Table 1). 
Whereas Cx43 was moderately reduced in  Cx43MAPKmut 
mice, a more severe reduction of the protein was detected 
in  Cx43CK1mut mice and especially in  Cx43PKCmut mice (all 
strains p < 0.05). The phosphorylation of Cx43 was analyzed 
by Western blot at S262, S325/328/330, S365, S368, and 
S373. Antibodies against Cx43 phosphorylated at S255, 
S279, and S282 could not be validated in initial Western Blot 
analyses; therefore, the Cx43 phosphorylation status at resi-
dues targeted by MAPK was based on S262 only. In total LV 
protein extracts of  Cx43MAPKmut mice, the ratio of phospho-
rylated over total Cx43 was not altered. In  Cx43PKCmut and 
 Cx43CK1mut mice, Cx43 phosphorylation was significantly 
decreased at S365, but increased at S262. Additionally, Cx43 
phosphorylation was diminished at S325/328/330 and S373 
in  Cx43PKCmut and at S368 in  Cx43CK1mut mice. Treatment 
of isolated cardiomyocytes from wild-type mice for 2 h or 
6 h with inhibitors against PKC (GF109203X) or CK1 (CKI-
7) did not increase Cx43 S262 phosphorylation or reduce 
Cx43 expression as in  Cx43PKCmut or  Cx43CK1mut mice (Sup-
plementary Fig. 1). As expected, no immunoreactivity was 
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detected using antibodies against S262 in  Cx43MAPKmut, 
against S368 in  Cx43PKCmut, and against S325/328/330 in 
 Cx43CK1mut mice, which proves the specificity of the anti-
bodies and the genotype of the mice (Supplementary Fig. 2).
SSM were isolated from LV tissue of WT,  Cx43MAPKmut, 
 Cx43PKCmut, and  Cx43CK1mut mice, and the amount of iso-
lated proteins per mg LV tissue was quantified. An exem-
plary Western Blot demonstrating the purity of mitochon-
drial preparations is demonstrated in Supplementary Fig. 3. 
A trend towards reduced amounts of isolated SSM was found 
in  Cx43CK1mut mice; however, there was no significant dif-
ference (amount of isolated SSM in µg protein/mg LV tis-
sue: WT: 2.34 ± 0.18, n = 8;  Cx43MAPK: 1.72 ± 0.42, n = 5; 
 Cx43PKCmut: 2.13 ± 0.25, n = 5;  Cx43CK1mut: 1.50 ± 0.17, 
n = 6, p = ns). Western Blot analysis was performed to char-
acterize the amount of Cx43 in SSM isolated from LV tis-
sue of WT,  Cx43MAPKmut,  Cx43PKCmut, and  Cx43CK1mut mice 
(Table 1). Compared to total LV proteins, similar reductions 
of mitochondrial Cx43 were detected in  Cx43MAPKmut and 
 Cx43CK1mut, whereas a further decrease to 9 ± 2% was meas-
ured in  Cx43PKCmut SSM (all strains p < 0.05). The analysis 
of the phosphorylation status of mitochondrial Cx43 dis-
played decreased phosphorylation at S325/328/330 and S373 
in  Cx43MAPKmut mice. In mitochondria from  Cx43PKCmut 
mice, the Cx43 phosphorylation at S325/328/330 was 
reduced, but it was increased at S262, S365, and S373. In 
SSM isolated from  Cx43CK1mut mice, S262 was increasingly 
phosphorylated compared to WT SSM. Original Western 
blots and single values of the data presented in Table 1 are 
shown in the online supplement (Supplementary Figs. 4 
–11).
Since the relative phosphorylation of Cx43 and also 
the absolute amount of the phosphorylated protein may be 
important, Western blot data of phosphorylated Cx43 were 
also normalized to the housekeeping proteins GAPDH 
(LV proteins) or MnSOD (SSM proteins, Table 2). Due 
to the low amount of Cx43 in the  Cx43PKCmut mitochon-
dria, the amount of Cx43 phosphorylated at S262 and S365 
was reduced when normalized to MnSOD, whereas it was 
increased when normalized to total Cx43. The enhanced 
phosphorylation of S262 in  Cx43PKCmut and  Cx43CK1mut as 
seen by normalization to total Cx43 was not detected by 
normalization to GAPDH or MnSOD.
To investigate whether or not mutations at MAPK, 
PKC, and CK1 target sites within Cx43 influence mito-
chondrial function, respiration, ROS formation and 
MPTP opening were measured in SSM isolated from WT, 
 Cx43MAPKmut (Fig. 1),  Cx43PKCmut (Fig. 2), and  Cx43CK1mut 
Table 1  Phosphorylation of Cx43 in LV and SSM samples of  Cx43MAPKmut,  Cx43PKCmut, and  Cx43CK1mut mice
Western blot analysis was performed for Cx43 phosphorylated at S262, S325/328/330, S365, S368, or S373 on left-ventricular (LV) and subsar-
colemmal mitochondria (SSM) protein samples isolated from wild-type mice (WT) or  Cx43MAPKmut,  Cx43PKCmut, and  Cx43CK1mut mice. Phos-
phorylated Cx43 was normalized to total Cx43 and signal intensities are shown in arbitrary units (a.u.). Total Cx43 was normalized to GAPDH 
in LV and to MnSOD in SSM protein samples and signal intensities from  Cx43MAPKmut,  Cx43PKCmut or  Cx43CK1mut mice are shown in percentage 
of that in WT samples; n.d.: not determined, ns: not significant











Cx43 in % WT
WT
Cx43MAPKmut
LV n.d 0.51 ± 0.08, n = 8
0.54 ± 0.08, n = 8
p = ns
0.17 ± 0.04, n = 8
0.15 ± 0.07, n = 8
p = ns
0.53 ± 0.04, n = 8
0.41 ± 0.03, n = 7, 
p = 0.06
0.62 ± 0.15, n = 8
0.41 ± 0.05, n = 7,
p = ns
100 ± 15,5, n = 8




LV 0.55 ± 0.08, n = 6
2.16 ± 0.24, n = 6
p < 0.05
1.01 ± 0.1, n = 8
0.24 ± 0.03, n = 8
p < 0.05
0.35 ± 0.12, n = 8
0.02 ± 0.002, n = 8
p < 0.05
n.d 0.58 ± 0.12, n = 6
0.15 ± 0.02, n = 6
p < 0.05
100 ± 10.0, n = 8




LV 0.26 ± 0.06, n = 6
0.71 ± 0.15, n = 6
p < 0.05
n.d 0.87 ± 0.09, n = 6
0.50 ± 0.05, n = 6
p < 0.05
0.72 ± 0.03, n = 6
0.56 ± 0.06, n = 6
p < 0.05
0.62 ± 0.09, n = 6
0.41 ± 0.06, n = 6
p = ns
100 ± 13.6, n = 6




SSM n.d 0.42 ± 0.04, n = 7
0.30 ± 0.02, n = 10
p < 0.05
0.17 ± 0.02, n = 7
0.20 ± 0.03, n = 9
p = ns
0.87 ± 0.03, n = 8
0.98 ± 0.05, n = 11
p = ns
0.19 ± 0.02, n = 8
0.08 ± 0.01, n = 9
p < 0.05
100 ± 14.4, n = 8




SSM 0.22 ± 0.03, n = 8
0.35 ± 0.04, n = 8
p < 0.05
0.025 ± 0.003, 
n = 6
0.015 ± 0.003, 
n = 6
p < 0.05
0.38 ± 0.02, n = 8
0.87 ± 0.13, n = 8
p < 0.05
n.d 0.19 ± 0.02, n = 8
0.53 ± 0.05, n = 5
p < 0.05
100 ± 15.1, n = 6




SSM 0.14 ± 0.02, n = 6
0.49 ± 0.11, n = 6
p < 0.05
n.d 0.62 ± 0.08, n = 6
0.57 ± 0.05, n = 6
p = ns
0.52 ± 0.08, n = 6
0.49 ± 0.04, n = 5
p = ns
0.18 ± 0.05, n = 6
0.17 ± 0.08, n = 6
p = ns
100 ± 10.8, n = 6
61.5 ± 3.9, n = 5
p < 0.05
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mice (Fig. 3). Whereas basal respiration (both complex 1 
und 2 substrates) was not affected by mutating Cx43 phos-
phorylation sites, ADP-stimulated oxygen consumption 
of SSM respiring on complex 1 substrates was decreased 
in SSM from the three analyzed mouse strains, with the 
highest reduction in SSM of  Cx43CK1mut mice. Using com-
plex 2 substrates, ADP-stimulated respiration was dimin-
ished in  Cx43CK1mut SSM only. Despite a trend towards a 
reduced respiratory control rate (RCR; ADP-stimulated 
respiration/basal respiration) in  Cx43CK1mut SSM, there 
was no significant difference in the RCR between SSM 
isolated from WT mice and mice with mutated Cx43 phos-
phorylation sites. There was a trend towards a reduced 
oxygen consumption driven by N,N,N′,N′-tetramethyl-p-
phenylenediamine (TMPD)/ascorbate (complex 4 respira-
tion) and a significantly decreased uncoupled respiration 
using carbonyl cyanide 4-(trifluoromethoxy)phenylhy-
drazone (FCCP) in  Cx43CK1mut compared to WT SSM 
(Table 3). The protein amounts of complexes 1–5 of the 
electron transport chain were not altered in  Cx43MAPKmut 
and  Cx43PKCmut, whereas the level of complex 1 was sig-
nificantly enhanced in  Cx43CK1mut mice (Supplementary 
Fig. 12). ROS formation was similar between SSM iso-
lated from WT,  Cx43MAPKmut,  Cx43PKCmut, and  Cx43CK1mut 
mice. In addition, the analysis of calcium-induced MPTP 
opening revealed no differences between the analyzed 
mouse lines. The use of cyclosporine A (CsA) as an 
inhibitor of MPTP opening significantly enhanced the 
calcium retention capacity in all analyzed strains.
Cx43 hemichannel activity was compared between WT, 
 Cx43MAPKmut,  Cx43PKCmut, and  Cx43CK1mut mice using 
patch-clamp experiments. LV cardiomyocytes were voltage-
clamped at the resting potential of − 70 mV. Short caffeine 
applications were used to trigger Cx43 hemichannel activity, 
which is characterized by spiking unitary events superim-
posed on the macroscopic sodium/calcium exchanger (NCX) 
current [42] (Fig. 4a). Altering Cx43 phosphorylation on the 
MAPK, PKC, and CK1 target sites significantly reduced the 
amplitude and slowed down the kinetics of the NCX current 
compared to control (Fig. 4b, c). However, the changes in 
NCX transporter kinetics did not reflect an alteration of the 
subsarcolemmal calcium content (Fig. 4d), for which NCX is 
considered to be a valuable indicator [79]. Cx43 hemichan-
nel activity was significantly reduced in  Cx43CK1mut and in 
 Cx43PKCmut mice, but not in  Cx43MAPKmut mice (Fig. 4e).
To characterize the importance of Cx43 phospho-
rylation for myocardial I/R injury, isolated hearts were 
Langendorff-perfused and underwent a protocol of I/R 
(45  min ischemia and 120  min reperfusion) without 
and with IPC. Heart rate returned to 600  bpm in all 
groups within 10  min reperfusion and hemodynamic 
data are shown in Table 4. Hearts of WT,  Cx43MAPKmut, 
 Cx43PKCmut, and  Cx43CK1mut mice revealed similar infarct 
sizes after I/R (Fig. 5). Following IPC, infarct size was 
reduced in WT,  Cx43MAPKmut and  Cx43PKCmut hearts, 
Table 2  Phosphorylation of Cx43 in LV and SSM samples of  Cx43MAPKmut,  Cx43PKCmut, and  Cx43CK1mut mice
Western blot analysis was performed for Cx43 phosphorylated at S262, S325/328/330, S365, S368, and S373 on left-ventricular (LV) and sub-
sarcolemmal mitochondria (SSM) protein samples isolated from wild-type mice (WT) or  Cx43MAPKmut,  Cx43PKCmut, and  Cx43CK1mut mice. Sig-
nal intensities are shown in arbitrary units (a.u.). Phosphorylated Cx43 was normalized to GAPDH in LV samples and to MnSOD in SSM sam-
ples, n.d.: not determined, ns: not significant
Strain Sample P-S262 (a.u.) P-S325/328/330
(a.u.)
P-S365 (a.u.) P-S368 (a.u.) P-S373 (a.u.)
WT
Cx43MAPKmut
LV n.d 1.64 ± 0.60, n = 8
1.18 ± 0.23, n = 8
p = ns
0.48 ± 0.15 n = 8
0.35 ± 0.09, n = 8
p = ns
1.17 ± 0.26, n = 8
0.70 ± 0.0, n = 7,
p = ns
0.57 ± 0.17, n = 8




LV 0.74 ± 0.07, n = 6
0.90 ± 0.22, n = 6
p = ns
1.26 ± 0.18, n = 8
0.12 ± 0.03, n = 8
p < 0.05
0.76 ± 0.34, n = 8
0.02 ± 0.002, n = 8
p < 0.05
n.d 0.60 ± 0.13, n = 6




LV 0.27 ± 0.05, n = 6
0.48 ± 0.18, n = 6
p = ns
n.d 0.88 ± 0.13, n = 6
0.24 ± 0.04, n = 6
p < 0.05
0.92 ± 0.05, n = 6
0.40 ± 0.06, n = 6
p < 0.05
0.87 ± 0.20, n = 6




SSM n.d 0.53 ± 0.06, n = 7
0.45 ± 0.06, n = 10
p = ns
0.19 ± 0.04, n = 7
0.19 ± 0.04, n = 9
p = ns
0.66 ± 0.11, n = 8
0.63 ± 0.06, n = 11
p = ns
0.18 ± 0.02, n = 8




SSM 0.11 ± 0.0, n = 8
0.04 ± 0.005, n = 8
p < 0.05
0.50 ± 0.03, n = 6
0.03 ± 0.005, n = 6
p < 0.05
0.35 ± 0.04, n = 8
0.08 ± 0.01, n = 8
p < 0.05
n.d 0.11 ± 0.02, n = 8




SSM 0.08 ± 0.01, n = 6
0.22 ± 0.08 n = 6
p = ns
n.d 0.46 ± 0.11, n = 6
0.31 ± 0.04, n = 6
p = ns
0.56 ± 0.11, n = 6
0.33 ± 0.05, n = 5
p = ns
0.13 ± 0.02, n = 6
0.10 ± 0.03, n = 6
p = ns
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whereas IPC did not protect hearts of  Cx43CK1mut mice. 
In  Cx43Cre−ER(T)/fl hearts, which express 50% of Cx43 (an 
amount comparable to that in  Cx43CK1mut mice), infarct 
size after I/R with IPC was 77.8 ± 7.4% of the area at 
risk (n = 4, p = ns vs. WT), thereby indicating a loss of 
cardioprotection by IPC also in this strain. 
Discussion
The present study demonstrates that the specific phos-
phorylation of Cx43 at MAPK, PKC, or CK1 target sites 
influenced the phosphorylation and the amount of Cx43 
in LV and mitochondrial protein extracts. The respective 







































































































































Fig. 1  Mitochondrial function in  Cx43MAPKmut mice. a Mitochon-
drial oxygen consumption of SSM isolated from wild-type (WT) and 
 Cx43MAPKmut mice respiring on complex 1 or complex 2 substrates 
without (basal) and with ADP to stimulate respiration. WT: n = 9, 
 Cx43MAPKmut n = 9, *: p < 0.05 vs ADP WT as analyzed by two-
way ANOVA. b Original traces showing ROS formation detected 
by Amplex UltraRed fluorescence in arbitrary units (a.u.) from WT 
and  Cx43MAPKmut SSM. c Quantification of ROS formation (slope 
of Amplex UltraRed fluorescence in a.u./min) from WT (n = 5) and 
 Cx43MAPKmut SSM (n = 5), p = ns as analyzed by unpaired t test. d 
Original traces showing Calcium green 5 N fluorescence (in a.u.) of 
SSM isolated from WT and  Cx43MAPKmut mice. Every third minute, 
5 µmol/L  CaCl2 was added until a sudden increase in Calcium green 
5 N fluorescence occurred (↓) which reflects MPTP opening. Meas-
urements were performed without (con) and with Cyclosporine A 
(CsA), which was used as a positive control to inhibit MPTP open-
ing. e The number of calcium pulses which was necessary to induce 
MPTP opening was calculated from SSM of WT and  Cx43MAPKmut 
mice without (con) and with CsA. WT (n = 7),  Cx43MAPKmut (n = 7). 
Data were compared by two-way ANOVA
 Basic Research in Cardiology          (2021) 116:21 
1 3
  21  Page 8 of 18
mutations in the three mouse lines altered mitochondrial 
oxygen consumption without effects on ROS formation and 
MPTP opening. Hemichannel activity was reduced in car-
diomyocytes of  Cx43PKCmut and  Cx43CK1mut mice, whereas 
the cardioprotection by IPC was abrogated in  Cx43CK1mut 
mice only.
At first, we analyzed the expression and phosphorylation 
of Cx43 in total LV proteins extracted from  Cx43MAPKmut, 
 Cx43PKCmut, and  Cx43CK1mut mice. Compared to WT pro-
teins, we detected a moderate decrease in total Cx43 in 
 Cx43MAPKmut mice. The analysis of the amount of Cx43 
in this strain in vascular smooth muscle cells did not dem-
onstrate reduced levels of Cx43, which may be due to the 
different tissue/cell types analyzed [34]. In  Cx43PKCmut and 
 Cx43CK1mut mice, we found a similar decrease of Cx43 in 
mouse hearts as previously published [30, 54, 70]. Whereas 
others suggested that the decreased Cx43 protein levels in 
 Cx43CK1mut mice are due to posttranscriptional alterations 
[70], the reason for the reduced Cx43 protein amount in 
 Cx43MAPKmut,  Cx43PKCmut, and  Cx43CK1mut mice remains 
unclear. Pharmacological inhibition of PKC or CK1 did not 
reduce Cx43 expression as in  Cx43PKCmut and  Cx43CK1mut 
mice, indicating that those interventions are not able to 
mimic the complex situation in vivo, where reduced gap 
junctional stability and Cx43 down-regulation are observed 
[54, 67, 70]. A failure to reduce Cx43 phosphorylation and 
amount of the whole-cell protein under baseline conditions 
using PKC and CK1 inhibitors has already been shown in 
Fig. 2  Mitochondrial function 
in  Cx43PKCmut mice. a Mito-
chondrial oxygen consumption 
of SSM isolated from wild-type 
(WT) and  Cx43PKCmut mice 
respiring on complex 1 or 
complex 2 substrates without 
(basal) and with ADP to stimu-
late respiration. WT: n = 11, 
 Cx43PKCmut n = 11, *p < 0.05 
vs ADP WT as analyzed by 
two-way ANOVA. b Original 
traces showing ROS formation 
detected by Amplex UltraRed 
fluorescence in arbitrary units 
(a.u.) from WT and  Cx43PKCmut 
SSM. c Quantification of ROS 
formation (slope of Amplex 
UltraRed fluorescence in a.u./
min) from WT (n = 7) and 
 Cx43PKCmut SSM (n = 7), p = ns, 
data were compared by unpaired 
t-test. d Original traces showing 
Calcium green 5 N fluorescence 
(in a.u.) of SSM isolated from 
WT and  Cx43PKCmut mice. 
Every third minute, 5 µmol/L 
 CaCl2 was added until a sud-
den increase in Calcium green 
5 N fluorescence occurred (↓) 
which reflects MPTP opening. 
Measurements were performed 
without (con) and with Cyclo-
sporine A (CsA), which was 
used as a positive control to 
inhibit MPTP opening. e The 
number of calcium pulses which 
was necessary to induce MPTP 
opening was calculated from 
SSM of WT and  Cx43PKCmut 
mice without (con) and with 
CsA. WT (n = 7),  Cx43PKCmut 
(n = 7). Data were compared by 
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different cell types, including cardiomyocytes [13, 15, 58, 
69, 78, 82].
We addressed the question whether the mutation of 
phosphorylation sites within Cx43 influences the phos-
phorylation status at other serine residues. The analyses 
of LV total proteins of  Cx43PKCmut and  Cx43CK1mut mice 
demonstrated alterations of Cx43 phosphorylation at all 
residues analyzed, whereas such distinct phosphorylation 
was not observed in  Cx43MAPKmut mice. Our data confirm 
a previous study showing enhanced phosphorylation of 
Cx43 at S262 in  Cx43CK1mut mice [70]. Therefore, muta-
tions of S325/328/330 or S368 are sufficient to induce 
significant changes in Cx43 phosphorylation at multiple 
residues including both enhanced and reduced phosphoryl-
ation at other amino acids. Possibly, the phosphorylation 
status of Cx43 has an impact on the binding of kinases or 
phosphatases and may thereby effect the phosphorylation 
of other target proteins [70].
In  Cx43MAPKmut and  Cx43CK1mut mice, we found com-
parable reductions of Cx43 in total and in mitochondrial 
protein extracts, whereas in  Cx43PKCmut mice, Cx43 was 
further reduced. Thus, the phosphorylation of Cx43 at 
S368 is important for the mitochondrial amount of Cx43. 
Yet, the mechanisms that prevent a mitochondrial translo-
cation of Cx43 not phosphorylated at S368 remain unclear.
Previous studies indicated a phosphorylation of mito-
chondrial Cx43 at S262 [73] and S368 [64, 73] and these 
findings are confirmed in the present analysis. Additionally, 
we detected a phosphorylation of mitochondrial Cx43 at 
S325/328/330, S365, and S373, which demonstrates that 
Fig. 3  Mitochondrial function 
in  Cx43CK1mut mice. a Mito-
chondrial oxygen consumption 
of SSM isolated from wild-type 
(WT) and  Cx43CK1mut mice 
respiring on complex 1 or com-
plex 2 substrates without (basal) 
and with ADP to stimulate res-
piration. WT: n = 6,  Cx43CK1mut 
n = 6, *p < 0.05 vs ADP WT as 
analyzed by two-way ANOVA. 
b Original traces showing 
ROS formation detected by 
Amplex UltraRed fluorescence 
in arbitrary units (a.u.) from 
WT and  Cx43CK1mut SSM. c 
Quantification of ROS forma-
tion (slope of Amplex UltraRed 
fluorescence in a.u./min) from 
WT (n = 8) and  Cx43CK1mut 
SSM (n = 8), p = ns, data were 
compared by unpaired t test. d 
Original traces showing calcium 
green 5 N fluorescence (in a.u.) 
of SSM isolated from WT and 
 Cx43CK1mut mice. Every third 
minute, 5 µmol/L  CaCl2 was 
added until a sudden increase in 
Calcium green 5 N fluorescence 
occurred (↓) which reflects 
MPTP opening. Measurements 
were performed without (con) 
and with Cyclosporine A (CsA), 
which was used as a positive 
control to inhibit MPTP open-
ing. e The number of calcium 
pulses which was necessary to 
induce MPTP opening was cal-
culated from SSM of WT and 
 Cx43CK1mut mice without (con) 
and with CsA. WT (con: n = 6; 
CsA: n = 5) and  Cx43CK1mut 
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under physiological conditions, the mitochondrial fraction 
of the protein is phosphorylated at multiple residues.
The pattern of Cx43 phosphorylation differed between 
total LV and mitochondrial proteins in  Cx43MAPKmut, 
 Cx43PKCmut, and  Cx43CK1mut mice. We cannot judge from 
the present data if only Cx43 with a specific phosphorylation 
pattern is imported into the mitochondria, or if the phospho-
rylation status of the protein is achieved within the organelle. 
Since several kinases and phosphatases have been detected 
in mitochondria [41], the latter is also possible.
We addressed the question whether the mutation of 
Cx43 phosphorylation sites alters mitochondrial function. 
Compared to wild-type mitochondria, mitochondria from 
 Cx43MAPKmut and  Cx43PKCmut mice revealed a moderate, 
but significant reduction of ADP-stimulated oxygen con-
sumption when respiring on complex 1 substrates, whereas 
mitochondria from  Cx43CK1mut showed decreased oxygen 
consumption when respiring on complex 1 and complex 2 
substrates. Also, the uncoupled respiration in the presence of 
FCCP, which indicates the maximum rate of respiration that 
can be achieved within the mitochondrial preparation, was 
diminished in  Cx43CK1mut mitochondria and there was also a 
trend towards a reduced TMPD/ascorbate-stimulated (com-
plex 4) respiration. Therefore, the mutation of CK1 phospho-
rylation sites within Cx43 generally impairs mitochondrial 
oxygen consumption. We already showed a specific decrease 
of complex 1-mediated respiration in mitochondria isolated 
from inducible Cx43-knockout mice [7], which contain 
about 10% Cx43, and hypothesized that the mitochondrial 
amount of Cx43 is important for mitochondrial function. 
Interestingly, in the present study, we detected similar reduc-
tions of oxygen consumption in mitochondria isolated from 
 Cx43MAPKmut and  Cx43PKCmut mice containing either 73% or 
9% Cx43, whereas the highest limitation in complex 1-medi-
ated respiration was found in mitochondria from  Cx43CK1mut 
mice containing about 62% Cx43. Therefore, it is unlikely 
that the influence of Cx43 on mitochondrial respiration is 
caused by a reduction in the amount of the protein only; 
rather, the phosphorylation status of Cx43 is involved in 
the regulation of mitochondrial oxygen consumption. Since 
Cx43 phosphorylation at S262 is absent in  Cx43MAPKmut 
mice and the phosphorylation at this residue is increased 
in mitochondria of  Cx43PKCmut and  Cx43CK1mut mice, the 
importance of Cx43 S262 for respiration can presumably be 
neglected. The confinement of respiration correlated with 
the phosphorylation status at S325/328/330, which was 
higher in  Cx43MAPKmut than in  Cx43PKCmut and absent in 
 Cx43CK1mut mitochondria. The finding that the amount of 
complex 1 of the electron transport chain is enhanced in 
 Cx43CK1mut mice suggests that the efficiency of the electron 
transport chain is decreased in this mouse strain.
ROS formation is decreased after inhibition of Cx43 
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Mitochondrial Cx43 is involved in the regulation of MPTP 
(which occurs at the onset of reperfusion, leads to mitochon-
drial swelling, and finally cell death) as shown by an acceler-
ated calcium-induced MPTP opening in cardiac mitochon-
dria after inhibition of Cx43 with the mimetic peptide Gap27 
or 18 alpha-glycyrrhetinic acid [8, 73]. In contrast, increased 
mitochondrial calcium retention capacity was measured in 
cardiac mitochondria upon Cx43 inhibition; however, these 
experiments were performed while blocking the mitochon-
drial calcium uniporter [20]. In the present study, ROS for-
mation and calcium-induced MPTP opening were similar in 
WT,  Cx43MAPKmut,  Cx43PKCmut, and  Cx43CK1mut mitochon-
dria. Taking into account that the mitochondrial amount of 
Cx43 significantly differs between the three mouse lines 
without having consequences for ROS formation and MPTP 
opening, the present study again emphasizes that not only 
the amount of Cx43 but also posttranslational modifications 
are important for mitochondrial function.
The role of Cx43 phosphorylation in cardiac I/R injury 
has been addressed in several studies. Whereas an altera-
tion of the phosphorylation status of Cx43 is observed 
with ischemia, the specific phosphorylation of Cx43 
Fig.4  Effect of altered Cx43 
phosphorylation on hemichan-
nel gating. a Representative 
sodium/calcium exchanger 
(NCX) current traces with 
superimposed Cx43 unitary 
current events triggered by 
caffeine (10 mmol/L) at Vh = − 
70 mV. b Average data showing 
significantly reduced normal-
ized NCX peak amplitudes in 
 Cx43MAPKmut,  Cx43PKCmut, and 
 Cx43CK1mut cardiomyocytes 
compared to wild-type (WT) 
cells. NCX currents were 
normalized on the cell capacity 
to minimize the difference due 
to cell size. c Summary data 
illustrating the time constant of 
the recovery phase in cardio-
myocytes of WT,  Cx43MAPKmut, 
 Cx43PKCmut, and  Cx43CK1mut 
mice. d Overall sarcoplasmic 
reticulum calcium equilibrium. 
e Quantification of the Cx43 
hemichannel open probability 
demonstrating reduced single-
channel activity in  Cx43PKCmut 
and  Cx43CK1mut mice compared 
to control conditions. WT 
(N = 6; n = 31),  (Cx43MAPKmut 
(N = 9; n = 26),  Cx43PKCmut 
(N = 3; n = 19),  Cx43CK1mut 
(N = 4; n = 20),). *p < 0.05; 
**p < 0.01; ***p < 0.001; 
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on S325/328/330 [2, 37], S365 [2, 71], S368 [17, 76], 
and S373 [2, 14] depends on the model and the duration 
of ischemia. However, several studies demonstrate that 
ischemia is associated with dephosphorylation of Cx43, a 
lateralization of the protein from the gap junctions and a 
subsequent internalization of the protein [60]. As a conse-
quence of I/R, the interactions between Cx43 and its binding 
partners are altered [44], an effect potentially contributing 
to decreased electrical and chemical gap junctional cou-
pling during ischemia [46]. Yet, the present study did not 
directly investigate the effect of Cx43 phosphorylation on 
gap junctional coupling in myocardial I/R injury. An open-
ing of Cx43-formed hemichannels is known to contribute 
to I/R injury [65, 81]. Hemichannel opening is regulated 
via Cx43 phosphorylation, e.g., the mutation of the PKC 
site S368 to alanine reduces hemichannel opening (for 
review see [52]) and astrocytes of  Cx43MAPKmut mice dis-
play diminished hemichannel activity [19]. Recently, it was 
shown that in a model of Duchenne muscular dystrophy the 
mutation of S325/328/330 to phospho-mimicking glutamic 
acids increased hemichannel opening [28]. However, the 
replacement of S325/328/330 to alanine or aspartate resi-
dues both enhances hemichannel opening [18]. Here, we 
describe decreased hemichannel activity in  Cx43PKCmut and 
 Cx43CK1mut, but not in  Cx43MAPKmut cardiomyocytes. There-
fore, we confirm previous data on the role of PKC-mediated 
Cx43 phosphorylation for hemichannel opening, whereas 
the contribution of MAPK and CK1 signaling on Cx43 





























































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 5  Influence of Cx43 phosphorylation on the cardioprotection 
by IPC in vitro. Infarct sizes (in % of the area at risk) are shown for 
wild-type (WT),  Cx43MAPKmut,  Cx43PKCmut, and  Cx43CK1mut mice 
subjected to ischemia/reperfusion (I/R) or ischemic precondition-
ing (IPC) in vitro. In addition to the individual infarct sizes of each 
animal, the mean value ± SEM of each group is presented, WT (I/R: 
n = 9, IPC: n = 8),  Cx43MAPKmut (I/R: n = 6, IPC; n = 6),  Cx43PKCmut 
(I/R: n = 6, IPC; n = 6),  Cx43CK1mut (I/R: n = 6, IPC; n = 6), data were 
compared by two-way ANOVA
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cell type analyzed. It is interesting to note, that although 
probability of hemichannel opening was partially reduced, 
the extent of I/R injury was similar between the different 
mouse strains.
It is likely that Cx43 phosphorylation is involved in 
cardioprotection, since pharmacological strategies which 
reduce myocardial damage following I/R are often associ-
ated with preserved Cx43 phosphorylation [60]. Moreover, 
the mutation of S368 to alanine abolishes the cardioprotec-
tion by sphingosine-1-phosphate [48]. However, the similar 
infarct sizes following I/R we observed in all strains ana-
lyzed argue against an influence of Cx43 phosphorylation at 
MAPK, PKC, or CK1 target sites on myocardial I/R injury 
per se. Similar infarct sizes in WT and  Cx43CK1mut mice have 
already been demonstrated after myocardial I/R in animals 
less than 1 year old [70]. However, it must be considered 
that in the analyzed mouse strains—especially in  Cx43PKCmut 
mice—not only the phosphorylation of Cx43 but also the 
total amount of the protein is reduced. Previous studies in 
mice with 50% Cx43 demonstrate decreased myocardial 
infarction following permanent coronary ligation [36], but 
no influence of the reduced protein amount on infarct size 
after acute I/R [59, 62].
Data showing that ischemia induces dephosphorylation 
of Cx43 lead to the hypothesis that the cardioprotection 
by IPC may prevent such dephosphorylation, and indeed, 
IPC enhances Cx43 phosphorylation (S262 and S368) both 
in vitro and in vivo [56, 61, 72]. It is suggested that the 
cardioprotection by IPC is mediated at least in part via sup-
pressing chemical gap junctional communication [46, 60], 
but also mitochondrial Cx43 seems to play a role [40, 55]. 
A reduction of Cx43 to about 50% in constitutive knockout 
mice is sufficient to abrogate IPC’s cardioprotection in vivo 
[62] and in vitro (present study with  Cx43Cre−ER(T)/fl mice); 
however, others demonstrate that IPC reduces infarct size 
in vitro in inducible Cx43 knockout mice expressing half 
the level of Cx43 [59]. In the present study, we showed that 
 Cx43PKCmut mice expressing around 40% of normal Cx43 
levels were effectively protected by IPC in vitro, whereas 
in  Cx43CK1mut mice with 54%, the level of Cx43 of the car-
dioprotection by IPC was lost. These data argue that Cx43 
expression levels alone cannot explain IPC effects and indi-
cate the importance of posttranslational modifications. Our 
data indicate that the phosphorylation of Cx43 at MAPK 
and PKC-target sites is not essential for the cardioprotection 
by IPC, but highlight the role of CK1-targeted residues for 
the reduction of myocardial I/R damage. Moreover, the loss 
of infarct size reduction by IPC in  Cx43CK1mut mice corre-
lated with the highest S262 phosphorylation of mitochon-
drial Cx43. Whereas opening of Cx43-formed hemichan-
nels during ischemia is known to contribute to myocardial 
I/R damage, our finding of reduced hemichannel activity 
in  Cx43CK1mut mice makes it unlikely that hemichannel 
opening is involved in the loss of cardioprotection by IPC 
in these mice. Cardiomyocytes of  Cx43CK1mut mice—similar 
to  Cx43MAPKmut and  Cx43PKCmut mice—displayed reduced 
NCX currents, suggesting that targeting phosphorylation on 
the Cx43 C-terminal residues can control channel gating 
and affects the kinetic of the NCX, one of the regulators of 
intracellular calcium homeostasis.  Ca2+ entry via reverse 
mode NCX contributes to myocardial I/R injury [31]. Since 
our data demonstrated reduced NCX currents in all three 
mouse lines with mutated Cx43 phosphorylation sites, NCX-
mediated currents are unlikely to explain the loss of cardio-
protection specifically in  Cx43CK1mut mice.
Mitochondria are important targets in the transduction 
of myocardial conditioning [6]. Reduction of mitochon-
drial Cx43 (without affecting gap junctional Cx43) abro-
gates pharmacological preconditioning [55], whereas the 
overexpression of mitochondrial Cx43 induces cytoprotec-
tion [43], pointing to an important role of the amount of 
mitochondrial Cx43 in cardioprotection. However, such 
direct correlation between the level of mitochondrial Cx43 
and cardioprotection by IPC is not supported by the pre-
sent data. Heterozygous Cx43-deficient mice have a spe-
cific deficit in ROS formation in response to diazoxide, and 
accordingly, the cardioprotection by pharmacological pre-
conditioning with diazoxide is lost [24]. Yet, the present 
study demonstrates that neither the reduction of mitochon-
drial Cx43 by more than 50% nor the mutation of Cx43 
phosphorylation sites modified ROS formation per se. In 
line with these findings, myocardial infarct size following 
I/R was similar among all mice strains. MPTP opening is 
regulated by Cx43, since pharmacological inhibition of 
Cx43 decreases the calcium retention capacity and thereby 
accelerates MPTP opening [8, 73]. In I/R injury, MPTP 
opening at reperfusion contributes to irreversible myo-
cardial damage; a similar MPTP opening was found in 
 Cx43MAPKmut,  Cx43PKCmut, and  Cx43CK1mut mitochondria 
which went along with an unaltered infarct size following 
I/R but also argues against its importance for the attenua-
tion of cardioprotection by IPC in  Cx43CK1mut mice. With 
reperfusion after prolonged ischemia, the combination of 
still elevated calcium concentrations and restored ATP 
levels via oxidative phosphorylation leads to cardiomyo-
cyte hypercontracture and finally to cell death [21]. The 
decreased oxygen consumption measured in  Cx43CK1mut 
mitochondria might possibly limit the generation of ATP 
at reperfusion and may thereby be beneficial; however, 
similar infarct sizes in WT and  Cx43CK1mut hearts do not 
favor an involvement of CK1-mediated Cx43 phosphoryla-
tion in cardiomyocyte hypercontracture. Several studies 
show that in the cardioprotection by IPC preserved mito-
chondrial energetics by maintaining mitochondrial oxy-
gen consumption limits cell death after myocardial I/R 
injury [6]. In the present study, impaired respiration was 
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measured especially in  Cx43CK1mut mitochondria. Whereas 
this finding suggests that limited oxygen consumption in 
 Cx43CK1mut mitochondria may be important for the loss of 
infarct size reduction by IPC in  Cx43CK1mut mice in vitro, 
the exact contribution of mitochondrial Cx43 (total 
amount and phosphorylated Cx43) towards the cardiopro-
tection by IPC remains unclear.
Study limitations—1. In the present study, we used 
genetically modified mice in which Cx43 phosphorylation 
sites are constitutively altered. These mice may carry some 
unrecognized additional mutations, which may also influ-
ence cellular and/or mitochondrial function.
2. Myocardial infarction after I/R injury may differ 
between isolated buffer-perfused hearts—as performed in 
the present study—and the in vivo situation. Therefore, 
we cannot exclude that  Cx43MAPKmut,  Cx43PKCmut, and 
 Cx43CK1mut mice will show a different response towards a 
preconditioning stimulus in the in vivo situation. Thus, the 
evaluation of infarct size without and with IPC in vivo will 
represent an important extension of the present study.
3. In addition, it has to be noted that mitochondrial func-
tion and electrophysiological measurements were performed 
at 25 °C or room temperature. Whereas mitochondrial oxy-
gen consumption is generally lower at 25 °C compared to 
37°, the temperature sensitivity of mitochondrial respira-
tion is dependent on the type of substrates and is lowest for 
glutamate and malate [38], the complex 1 substrates used 
in the present study. While data show that Cx26-formed 
hemichannels are sensitive to changes in the temperature 
[74, 80], Cx43 hemichannel gating mechanisms are not 
affected by temperature [51, 57], and therefore, the major-
ity of studies investigating Cx43 hemichannels were com-
monly performed at room temperature [3, 33, 35, 45, 53, 60]. 
Importantly, since experiments on mitochondrial function 
and electrophysiological recordings were carried out at the 
same temperatures, differences in respiration and hemichan-
nel activity between the mouse strains cannot be attributed 
to temperature variances.
Taken together, our data show that the mutation of 
Cx43 phosphorylation sites targeted by MAPK, PKC, or 
CK1 to non-phosphorylatable residues affects the amount 
and the phosphorylation of Cx43 at amino acids not 
directly targeted by the mutations and thereby emphasizes 













































1 and 2 respiration:
hemichannel opening:
ischemic preconditioning:
Fig. 6  The role of Cx43 phosphorylation for specific cellular func-
tions. The scheme shows the topology of Cx43 including the trans-
membrane domains (1–4) and important phosphorylation sites, which 
are indicated by filled circles and are numbered according to their 
positions. ↓: decreased/impaired function, ✓: normal function
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modifications and the amount of the Cx43 protein. The 
alterations of the amounts/phosphorylation of Cx43 have 
consequences for specific cellular function, since mutation 
of Cx43 phosphorylation sites for MAPK, PKC, and CK1 
sites reduces mitochondrial respiration, mutation of PKC 
and CK1 sites decreases hemichannel activity, and the 
mutation of Cx43 residues targeted by CK1 abrogates the 
infarct size reduction by IPC (Fig. 6). Therefore, in addi-
tion to Cx43 phosphorylation at S262 and S368, phospho-
rylation at S325/328/330 is involved in mediating IPC’s 
cardioprotection, an effect independent from the protein 
amount of Cx43 and Cx43-mediated hemichannel opening.
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